subslover
1月前
PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets
Platform builds on NVIDIA Connect participation and previously announced weather-domain patent filing to address forecasting accuracy, imbalance exposure, storage optimization and real-time market decision-making
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.
DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.
DeepSolar Predict is being developed with the goal of helping renewable asset owners, operators, and energy market participants improve production forecasting, optimize energy commitments, reduce imbalance exposure, and support higher-value delivery decisions across solar, wind, and battery energy storage assets.
The platform builds on PRF’s previously announced DeepSolar initiatives, including DeepSolar’s participation in the NVIDIA Connect Program and the Company’s patent application covering proprietary methods for plant-level micro-climate modeling designed to improve solar energy production forecast accuracy in competitive electricity markets.
PRF believes renewable energy markets are entering a new phase in which asset owners can no longer rely solely on generation volume, traditional monitoring or standalone forecasting tools. As renewable penetration increases, operators must continuously manage localized weather variability, production uncertainty, imbalance penalties, curtailment risk, grid constraints, storage utilization and real-time market opportunities.
DeepSolar Predict is designed to address these challenges through a unified AI-driven platform that connects the full renewable asset workflow — from weather intelligence and production forecasting to commitment optimization, storage orchestration, delivery planning and real-time market decision support.
The Company believes this integrated approach differentiates DeepSolar Predict from many existing market solutions that address only isolated parts of the renewable energy value chain. DeepSolar Predict is being developed to help operators convert complex operational and market data into actionable decisions intended to improve asset-level economics.
Key planned capabilities of DeepSolar Predict include:
Localized weather intelligence: plant- and asset-level weather modeling designed to improve short-term and intraday renewable production forecasts;
Production forecasting: AI-driven forecasting intended to support more accurate day-ahead and intraday energy commitments;
Imbalance risk management: tools designed to help operators reduce exposure caused by differences between committed and actual energy delivery;
Storage optimization: decision support for battery energy storage systems, including when to store, dispatch or preserve capacity based on market conditions;
Portfolio-level optimization: analytics intended to support renewable operators managing multiple assets across different geographies, grid conditions and market structures;
Real-time market decision support: market-informed analytics designed to help operators identify higher-value delivery opportunities.
“Renewable energy operators are no longer managing only production — they are managing financial exposure in increasingly dynamic power markets,” said Dr. Ehud Geller, Chairman of PRF Technologies. “We believe DeepSolar Predict represents an important expansion of the DeepSolar platform from asset analytics and forecasting into AI-driven revenue optimization. By combining localized weather behavior, production intelligence, grid dynamics, storage flexibility and market conditions, our goal is to help customers move from reactive operations to proactive, data-driven revenue optimization.”
PRF believes DeepSolar Predict is positioned to support a growing need among renewable asset owners, independent power producers, infrastructure investors and energy market participants seeking to improve forecasting accuracy, protect margins and maximize asset value as renewable portfolios scale globally.
The Company’s DeepSolar platform has already advanced across multiple commercial and strategic initiatives, including solar analytics deployments, technical due diligence services, commercial collaboration agreements and development of proprietary forecasting technologies. PRF believes the planned launch of DeepSolar Predict would represent an important next step in expanding DeepSolar from solar asset analytics into broader AI-driven renewable energy optimization.
About DeepSolar
DeepSolar develops advanced digital asset-management technologies for utility-scale renewable energy assets. Its AI-driven algorithms are designed to transform complex operational data into actionable insights — detecting issues, forecasting production, supporting operational decision-making and helping asset owners improve performance and profitability. DeepSolar is an active participant in the NVIDIA Connect program, supporting continued innovation in AI-powered renewable energy solutions.
About PRF Technologies
PRF Technologies (Nasdaq: PRFX) is a company focused on the reformulation of established therapeutics, and a
subslover
5月前
PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar’s Installed Commercial Base
Shikun & Binui Energy Selects DeepSolar SaaS Starting with a 71 MW Solar Project, Reinforcing Adoption by European Infrastructure Operators
TEL AVIV, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- PRF Technologies (Nasdaq: PRFX) (“PRF” or the “Company”), through its DeepSolar™ AI-driven solar analytics business unit, today announced the signing of a software-as-a-service (SaaS) agreement with Shikun & Binui Energy for the deployment of DeepSolar at the 71 megawatt (MW) Satu Mare photovoltaic site in Romania.
The Satu Mare project is a utility-scale solar plant owned and operated by Shikun & Binui Energy. Under the agreement, DeepSolar will provide continuous analytics and performance monitoring designed to enhance operational visibility, support proactive asset management, and enable data-driven decision-making throughout the project’s operating life.
Unlike pilot programs, this agreement reflects a commercial SaaS deployment supporting ongoing plant operations.
Shikun & Binui Energy is the renewable-energy subsidiary of Shikun & Binui Ltd. (TASE: SKBN), one of Israel’s leading infrastructure and construction groups, with decades of experience and active operations across infrastructure, energy, real estate, and concessions in Israel and international markets. The deployment at Satu Mare reflects Shikun & Binui Energy’s continued expansion in European renewable-energy markets, including Romania.
DeepSolar applies advanced analytics and machine-learning techniques to historical and real-time operational data from utility-scale solar plants. The platform is designed to identify performance trends, detect operational anomalies, and support informed operational and commercial decision-making under varying market and grid conditions.
“This agreement represents another step forward in the commercial rollout of DeepSolar with established infrastructure and renewable-energy operators,” said Dr. Ehud Geller, Chairman and Chief Executive Officer of PRF Technologies. “As utility-scale solar portfolios grow larger and more complex, operators are increasingly adopting advanced analytics to improve asset performance, manage risk, and maximize long-term value. We believe DeepSolar is well positioned to support these objectives across Europe and other international markets.”
The Satu Mare deployment builds on PRF Technologies’ recent DeepSolar commercial and strategic activity in Europe, including previously announced pilot and analytics engagements with utility-scale solar operators. The Company continues to expand DeepSolar’s capabilities and use cases, including performance monitoring, predictive analytics, and technical due-diligence applications for solar asset owners and investors.
In parallel with expanding deployments, PRF Technologies has been broadening DeepSolar’s product stack. Recent initiatives include the launch of Smart TDD, a technical due diligence solution designed to support solar asset transactions and lifecycle performance assessments, and continued development of DeepSolar Predict, the Company’s forecasting solution designed to improve energy production and revenue visibility. PRF has also filed a patent application related to plant-level micro-climate modeling, further strengthening its intellectual property position in solar analytics.
PRF Technologies believes this agreement supports its strategy to scale DeepSolar as a recurring SaaS platform for professional renewable-energy owners, infrastructure groups, and financial stakeholders across European and international solar markets.
About DeepSolar
DeepSolar develops advanced digital-asset-management technologies for utility-scale solar plants. Its AI-driven algorithms transform complex operational data into actionable insights - detecting issues, forecasting production, and improving decision-making to maximize asset performance and profitability. DeepSolar is an active participant in the NVIDIA Connect program (#NVIDIAConnect), supporting continued innovation in AI-powered renewable-energy solutions.
About PRF Technologies
PRF Technologies Ltd. (Nasdaq: PRFX) is a company focused on the reformulation of established therapeutics, and a developer of AI-driven energy optimization technologies through its DeepSolar platform. The Company’s pharmaceutical programs leverage a proprietary extended-release drug-delivery system intended to provide
subslover
6月前
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms
Shareholders Approved Name Change at January 6, 2026 Annual General Meeting as Company Evolves Beyond Single-Asset Focus
TEL AVIV, Israel, Jan. 15, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) (formerly “PainReform”) today announced its corporate name change to PRF Technologies Ltd. following shareholder approval at the Company’s Annual General Meeting held on Tuesday, January 6, 2026. The Company’s Nasdaq ticker symbol will remain PRFX.
The approved name change is intended to reflect the Company’s evolution into a diversified innovation platform spanning specialty pharmaceuticals, advanced drug-delivery technologies, and AI-driven renewable-energy analytics, marking a strategic shift beyond its original single-product focus.
Over the past 18 months, PRF has significantly broadened its portfolio across multiple large, high-growth markets. While the Company continues to advance PRF-110, its non-opioid extended-release postoperative pain therapy, it has also established two additional growth platforms through LayerBio and DeepSolar, each supported by differentiated technology and independent market opportunity.
“This name change reflects how fundamentally the Company has evolved,” said Dr. Ehud Geller, Chairman and Interim Chief Executive Officer. “We are no longer defined by a single program. We have built a diversified portfolio of platforms addressing large markets where precision delivery, data, and technology can drive meaningful improvement. We believe this move more accurately represents our strategy and direction.”
Expanding Pharmaceutical Platform Through LayerBio
Through its majority ownership of LayerBio, PRF has entered the ophthalmology market with OcuRing™-K, a patented, sustained-release, dropless ocular therapy designed to address pain and inflammation following cataract surgery—one of the most commonly performed surgical procedures worldwide and a multi-billion-dollar global market.
OcuRing™-K is designed to deliver controlled, localized therapy from a single intraoperative application, eliminating the need for weeks of post-surgical eye drops. The platform is non-opioid, non-steroidal, and bioerodible, and is being advanced toward the next stage of clinical development. Beyond cataract surgery, the LayerBio platform supports expansion into additional ophthalmic indications and therapeutic categories, providing a scalable pharmaceutical growth pathway.
Building a Scalable AI-Driven Energy Analytics Business with DeepSolar
In parallel, PRF has built DeepSolar, an AI-driven solar analytics and digital asset-management business designed to address the rapidly expanding global renewable-energy market. DeepSolar’s platform transforms complex operational, weather, and market data into actionable intelligence for utility-scale solar assets.
DeepSolar’s offerings include:
Smart TDD, a next-generation solar technical due diligence service supporting asset transactions, warranty reviews, commissioning, and underperformance diagnostics
DeepSolar Predict, an AI-based solar forecasting solution being developed within NVIDIA’s Connect Program, designed to materially improve production forecast accuracy
An automated AI reporting engine that accelerates insight generation and decision-making across the solar asset lifecycle
DeepSolar has progressed from development into early commercial deployment, with pilot projects advancing into customer engagements as solar assets age and transaction activity accelerates globally.
Positioning for the Next Phase of Growth
The approved transition to PRF Technologies Ltd. is intended to reflect the Company’s strategy to build long-term value through diversification, platform scalability, and disciplined execution across healthcare and clean-energy technology markets.
“Our approach is deliberate,” Geller added. “We are building a company with multiple platforms, multiple paths forward, and reduced reliance on any single outcome. That is the foundation we believe is necessary to build durable, long-term value.”
About PRF Technologies Ltd.
PRF Technologies Ltd. (Nasdaq: PRFX) is a diversified innovation company advancing specialty pharmaceutical therapies and AI-driven energy analytics. Its pharmaceutical programs focus on reformulation and sustained-release drug-delivery technologies designed to improve patient outcomes while reducing reliance on opioids and complex dosing regimens. Through its DeepSolar platform, the Company develops advanced AI solutions designed to enable solar asset owners and operators to monitor, forecast, and optimize energy performance across the full asset lifecycle.
For more information, please visit www.painreform.com.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements about PRF’s expectations, beliefs and intentions including with respect to PRF’s strategy to build long term value through diversification, platform scalability, and disciplined execution across healthcare and clean-energy technology markets. Forward-looking statements can be identified by the use of forward-looking words such as “believe”, “expect”, “intend”, “plan”, “may”, “should”, “could”, “might”, “seek”, “target”, “will”, “project”, “forecast”, “continue” or “anticipate” or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward- looking statements, including, but not limited to, the following: our ability to continue as a going concern, our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on
subslover
1年前
PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization Market
TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion into the rapidly growing Smart Energy Management (SEM) sector. This move follows the successful acquisition of DeepSolar, a cutting-edge provider of AI-driven software solutions designed to optimize solar energy usage in residential and utility-scale solar power plants.
This strategic expansion marks an important milestone in PainReform’s long-term diversification strategy, aimed at tapping into high-growth, tech-enabled markets. With global solar capacity accelerating amid increasing demand for decentralized, sustainable energy solutions, the ability to measure, analyze, and improve solar energy yield is more critical than ever. Optimization software has emerged as a foundational tool in this transition—driving both economic and environmental value for consumers and enterprises alike.
DeepSolar’s product, MyDeepSolar, is an application that leverages machine learning and predictive analytics to provide real-time monitoring, yield forecasting, and performance optimization for solar-enabled homes.
The app helps maximize the return on solar investments and optimize energy efficiency, by providing homeowners with comprehensive insights into their solar system's performance. It also provides full visibility of the system's status and losses, allowing users to compare actual energy production with the system's potential.
“Our expansion into Smart Energy Management not only aligns with global energy trends but also capitalizes on a technology platform with enormous commercial scalability,” said Ehud Geller, Chairman and interim CEO of PainReform. “We believe DeepSolar has the potential to play a transformative role in a market where intelligent optimization is the key to unlocking the full value of solar energy. The future of energy is decentralized, intelligent, and consumer-empowered—and we intend to be at the forefront of that evolution.”
PainReform’s entry into the SEM market comes amid a flurry of M&A activity and institutional investments in solar and smart energy technologies. Governments worldwide are also ramping up support for residential optimization through tax credits, net metering incentives, and smart grid infrastructure.
By entering a sector with strong macro tailwinds, PainReform is expanding its innovation footprint beyond its pharmaceutical roots, leveraging its AI expertise to address new verticals where data-centric platforms drive recurring revenue and operational scalability.
makinezmoney
1年前
$PRFX: Yupppppppppp........... $5 breaker.
There it goes.
PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity
February 18, 2025 08:30 ET
| Source: PainReform Ltd
Share
DeepSolar brings new customer base in creation, including major utility-scale
solar operators and independent power producers, while
breaking into the residential solar market
The Company remains committed to advancing its drug delivery
technologies while broadening its growth potential
TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it has executed a definitive agreement with BladeRanger Ltd, a public company registered under the laws of the State of Israel, whose shares are listed for trading on Tel Aviv Stock Exchange under the ticker “BLRN” (the “BLRN”) to acquire 100% of the business activity of DeepSolar, an AI-driven solar analytics platform owned by BLRN (the “Agreement”). This strategic acquisition represents a compelling and highly opportunistic move for PainReform. At the same time, the Company remains committed to advancing its drug delivery technologies, including pain treatment and other specialty pharmaceuticals. The acquisition is expected to close before the end of February 2025, subject to the satisfaction of customary closing conditions.
DeepSolar is a cutting-edge AI-powered analytics company that optimizes the efficiency and profitability of solar energy assets. DeepSolar leverages proprietary software and AI-driven automation tools, providing a significant competitive advantage in solar energy management. Its technology integrates seamlessly with SCADA systems via a centralized dashboard, offering real-time monitoring, performance analytics, and automated maintenance solutions.
Operating in both the B2B and B2C sectors, DeepSolar provides enterprise-level solutions for large-scale solar operators and residential applications for individual homeowners. In the commercial sector, its platform helps solar farms reduce operational inefficiencies and increase energy output. In the residential market, its mobile app empowers homeowners to optimize their solar investments, detect inefficiencies, and reduce energy costs. DeepSolar’s platform can cut operational costs by up to 30% while maximizing energy production, presenting a significant market opportunity across multiple verticals.
DeepSolar is in the process of establishing a diverse customer base, including major utility-scale solar operators, independent power producers, and residential solar system owners. Its AI-driven analytics platform is trusted by large-scale energy producers to optimize portfolio performance, aiming to ensure maximum uptime and efficiency. Additionally, DeepSolar’s residential mobile app "My DeepSolar" is expected to gain traction among homeowners seeking to monitor and enhance the performance of their solar installations.
“We are incredibly excited about the unique opportunity this acquisition presents,” said Ehud Geller, Chairman of PainReform. “While at first glance, a pharmaceutical company acquiring a solar analytics business may seem unconventional, the rationale is both compelling and strategic. DeepSolar operates in a rapidly growing, high-margin sector where AI-driven solutions are revolutionizing solar energy efficiency and profitability. Given the significant potential of this opportunity, we believe this move is designed for increasing our shareholders benefit.”
PainReform identified DeepSolar as an exceptional value-creation opportunity due to its advanced AI-based software, which optimizes solar energy production through real-time monitoring, performance analytics, and automated reporting tools. According to the SolarPower Europe report on the solar market from 2021–2026, the solar energy market is expanding rapidly, generating over 1 terawatt (TW) of energy and growing at an annual rate of 25.32%. DeepSolar’s technology enhances the profitability of solar assets by reducing operational costs, maximizing energy yield, and providing predictive analytics to drive better decision-making.
Under the terms of the Agreement, PainReform will receive all rights, title and interest in certain (i) the agreements, (ii) intellectual property, (iii) accounts receivable, (iv) equipment, (v) Deep Solar’s reputation and customer relations associated with their business, (vi) the “My DeepSolar” application and platform, and (vi) all rights, title and interest in, to or arising from any of the foregoing assets, properties and rights (whether real, personal or mixed, tangible or intangible, wherever located), each as set forth or defined in the Agreement (collectively, the “Acquired Assets”). In consideration for the sale of the Acquired Assets, BLRN is entitled to receive (1) 178,769 ordinary shares of the Company, representing 9.9% of the issued and outstanding share capital of PainReform (after such issuance); (2) 223,792 pre-funded warrants to purchase 223,792 ordinary shares; (3) 685,004 pre-funded milestone warrants to purchase 685,004 ordinary shares; (4) 1,087,565 warrants-A to purchase 1,087,565 ordinary shares; and (5) 1,087,565 warrants-B to purchase 1,087,565 ordinary shares (collectively, the “Securities”). In addition, certain employees of BLRN shall enter into employment agreements with PainReform.
Pursuant to the Agreement, BLRN may not exercise any of the pre-funded warrants, pre-funded milestone warrants, warrants-A or warrants-B held by it (or any assignee or transferee of BLRN), if, following such exercise, BLRN (including any assignee or transferee) holds shares of the Company which exceed 9.99% of the issued and outstanding share capital of PainReform.
From the date of execution of the Agreement until ninety (90) days after the date of closing of the business acquisition, PainReform may not (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any ordinary shares or ordinary share equivalents or (ii) file a registration statement or any amendment or supplement thereto, other than as contemplated pursuant to the Agreement. PainReform undertook to register the Securities with the Securities and Exchange Commission within sixty days from the date of the closing of the business acquisition.
Highlights of DeepSolar
AI-Driven Solar Management Platform – DeepSolar’s software provides comprehensive, real-time insights that optimize solar field productivity, offering a significant advantage over traditional legacy systems.
High-Margin, Scalable Business Model – The company’s platform-as-a-service model ensures recurring revenue, minimal overhead, and significant scaling potential in both commercial and residential solar markets.
Massive Market Opportunity – According to industry reports, the global residential solar market was valued at $94.2 billion in 2024. According to the Solar Industry Research Data report quotes, the global residential solar market alone was valued at $94.2 billion in 2024, and is estimated to grow by 8%/year until 2034
Cost-Reduction Capabilities – DeepSolar’s analytics reduce operational and maintenance (O&M) expenses by up to 30%, directly improving customers’ bottom lines.
Despite this diversification, PainReform remains committed to advancing its proprietary technologies and drug candidate focused on extended-release pain relief while exploring additional specialty pharmaceutical pipeline opportunities. The Company’s existing management team and Board of Directors remain in place, ensuring operational continuity while leveraging the financial and strategic advantages of the DeepSolar acquisition.
PainReform views this acquisition as a game-changing addition to its portfolio. By capitalizing on a rapidly growing sector with deep technological moats, the Company believes it is positioning itself for potential long-term growth while maintaining its focus on pharmaceutical innovation.
“This acquisition is about recognizing and seizing a unique opportunity that can profoundly impact our business,” added Geller. “DeepSolar’s cutting-edge analytics capabilities have the potential to position us at the forefront of a thriving industry while continuing our mission in the pharmaceutical sector.”
Additional details about the transaction are available in the Company’s Form 6-K, which has been filed with the Securities and Exchange Commission.
About PainReform
PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics. The Company's proprietary extended- release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. For more information, please visit www.painreform.com.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements about PainReform’s expectations, beliefs and intentions including with respect to the anticipated benefits to PainReform of the acquisition of DeepSolar, the anticipated market opportunity, the completion of the business acquisition and the satisfaction of customary closing conditions related to the business acquisition. Forward-looking statements can be identified by the use of forward-looking words such as "believe", "expect", "intend", "plan", "may", "should", "could", "might", "seek", "target", "will", "project", "forecast", "continue" or "anticipate" or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward- looking statements, including, but not limited to, the following: our ability to satisfy the conditions to closing the proposed transaction in the anticipated timeframe or at all; our ability to realize the anticipated benefits of the proposed transaction, including the possibility that the expected benefits from the proposed transaction will not be realized or will not be realized within the expected time period; the risk that the businesses will not be integrated successfully; our ability to continue as a going concern, our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on the success of our initial product candidate, PRF-110; the outcomes of preclinical studies, clinical trials and other research regarding PRF-110 and future product candidates; our limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact of competition and new technologies; our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others; the overall global economic environment; our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; our ability to maintain our listing on the Nasdaq Capital Market; and statements as to the impact of the political and security situation in Israel on our business, including due to the current war in Israel. More detailed information about the risks and uncertainties affecting us is contained under the heading "Risk Factors" included in the Company's most recent Annual Report on Form 20-F and in other filings that we have made and may make with the Securities and Exchange Commission in the future.
Contact:
Crescendo Communications, LLC
Tel: 212-671-1021
Email: prfx@crescendo-ir.com
Dr. Ehud Geller
Chairman and interim Chief Executive Officer PainReform Ltd.
Tel: +972-54-4236711
Email: egeller@medicavp.com
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Golden Cross
2週前
glenn1919
1月前
TrendTrade2016
5月前
gail
11月前
Monksdream
1年前
Zardiw
2年前
メールアドレスで登録
